IL96347A - Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cells - Google Patents
Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cellsInfo
- Publication number
- IL96347A IL96347A IL96347A IL9634790A IL96347A IL 96347 A IL96347 A IL 96347A IL 96347 A IL96347 A IL 96347A IL 9634790 A IL9634790 A IL 9634790A IL 96347 A IL96347 A IL 96347A
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- growth factor
- eukaryotic cells
- nerve growth
- factor expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT04856489A IT1238348B (it) | 1989-11-16 | 1989-11-16 | Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote. |
Publications (2)
Publication Number | Publication Date |
---|---|
IL96347A0 IL96347A0 (en) | 1991-08-16 |
IL96347A true IL96347A (en) | 1997-11-20 |
Family
ID=11267348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL96347A IL96347A (en) | 1989-11-16 | 1990-11-14 | Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cells |
Country Status (22)
Country | Link |
---|---|
US (1) | US5457034A (xx) |
EP (1) | EP0432510B1 (xx) |
JP (2) | JP3121611B2 (xx) |
KR (1) | KR910009929A (xx) |
CN (1) | CN1051934A (xx) |
AR (1) | AR246983A1 (xx) |
AT (1) | ATE214735T1 (xx) |
CA (1) | CA2030108C (xx) |
DE (1) | DE69033937T2 (xx) |
ES (1) | ES2173856T3 (xx) |
FI (1) | FI905691A (xx) |
HU (1) | HUT61047A (xx) |
IE (1) | IE904120A1 (xx) |
IL (1) | IL96347A (xx) |
IT (1) | IT1238348B (xx) |
NZ (1) | NZ236058A (xx) |
PE (1) | PE28191A1 (xx) |
PL (1) | PL287811A1 (xx) |
PT (1) | PT95911B (xx) |
TW (1) | TW205069B (xx) |
YU (1) | YU217890A (xx) |
ZA (1) | ZA909122B (xx) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5169762A (en) * | 1983-03-03 | 1992-12-08 | Genentech, Inc. | Human nerve growth factor by recombinant technology |
US6090781A (en) * | 1996-11-06 | 2000-07-18 | Genentech, Inc. | Stabilizing formulation for NGF |
US6964947B1 (en) | 1995-11-07 | 2005-11-15 | Genentech, Inc. | Stabilizing formulation for NGF |
US6495662B1 (en) * | 1998-10-22 | 2002-12-17 | The General Hospital Corporation | Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
ES2316354T3 (es) | 1999-09-29 | 2009-04-16 | The General Hospital Corporation | Derivados polipeptidos de la hormona paratiroidea (pth). |
WO2001023521A2 (en) * | 1999-09-29 | 2001-04-05 | The General Hospital Corporation | Polypeptide derivatives of parathyroid hormone (pth) |
EP1305040B1 (en) * | 2000-07-28 | 2009-09-09 | Christopher J. Murphy | Transplant media |
US7572765B2 (en) * | 2001-07-23 | 2009-08-11 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (PTH) analogs |
JP4334480B2 (ja) | 2003-03-19 | 2009-09-30 | ザ ジェネラル ホスピタル コーポレイション | α−ヘリックス安定化剤を用いる高次構造的に制約された副甲状腺ホルモン |
WO2005009358A2 (en) | 2003-07-17 | 2005-02-03 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (pth) analogs |
US20070207209A1 (en) * | 2004-08-27 | 2007-09-06 | Murphy Christopher J | Trophic factor combinations for nervous system treatment |
WO2008019062A2 (en) * | 2006-08-04 | 2008-02-14 | The General Hospital Corporation | Polypeptide derivatives of parathyroid hormone (pth) |
CN101260398B (zh) | 2007-03-07 | 2013-06-05 | 舒泰神(北京)生物制药股份有限公司 | 神经生长因子基因定位改造动物及其制备方法和应用 |
BRPI0814962B8 (pt) | 2007-08-01 | 2021-05-25 | Chugai Pharmaceutical Co Ltd | métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica |
CN101927012B (zh) * | 2009-06-26 | 2013-08-14 | 丽珠医药集团股份有限公司 | 神经生长因子的病毒灭活方法 |
JP5941040B2 (ja) | 2010-05-13 | 2016-06-29 | ザ ジェネラル ホスピタル コーポレイション | 副甲状腺ホルモン類似体およびその使用 |
CN102816766A (zh) * | 2012-05-04 | 2012-12-12 | 沈阳医学院 | 蛇毒神经生长因子活性多肽的筛选方法 |
US20240018481A1 (en) * | 2021-07-30 | 2024-01-18 | Chengdu Unovel Biopharma Co., Ltd. | Recombinant cho cell, construction method therefor, and detection system and method using same |
CN115894705A (zh) * | 2021-09-30 | 2023-04-04 | 三生国健药业(上海)股份有限公司 | 一种β-NGF融合蛋白、其制备方法及用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK161152C (da) * | 1983-03-03 | 1991-11-11 | Genentech Inc | Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat |
US4796580A (en) * | 1987-09-11 | 1989-01-10 | Allied-Signal Inc. | Idle control valve for use with a throttle assembly of an internal combustion engine |
JPH01211490A (ja) * | 1988-02-19 | 1989-08-24 | Tosoh Corp | ヒト神経成長因子遺伝子セグメント |
US5272063A (en) * | 1988-11-22 | 1993-12-21 | Syntex (U.S.A.) Inc. | Process of making human nerve growth factor |
-
1989
- 1989-11-16 IT IT04856489A patent/IT1238348B/it active IP Right Grant
-
1990
- 1990-11-13 NZ NZ236058A patent/NZ236058A/xx unknown
- 1990-11-14 IL IL96347A patent/IL96347A/xx active IP Right Grant
- 1990-11-14 ZA ZA909122A patent/ZA909122B/xx unknown
- 1990-11-15 IE IE412090A patent/IE904120A1/en unknown
- 1990-11-15 PT PT95911A patent/PT95911B/pt active IP Right Grant
- 1990-11-15 YU YU217890A patent/YU217890A/sh unknown
- 1990-11-15 PE PE1990177640A patent/PE28191A1/es unknown
- 1990-11-15 CA CA002030108A patent/CA2030108C/en not_active Expired - Fee Related
- 1990-11-16 PL PL28781190A patent/PL287811A1/xx unknown
- 1990-11-16 CN CN90109292A patent/CN1051934A/zh active Pending
- 1990-11-16 ES ES90121961T patent/ES2173856T3/es not_active Expired - Lifetime
- 1990-11-16 FI FI905691A patent/FI905691A/fi not_active IP Right Cessation
- 1990-11-16 EP EP90121961A patent/EP0432510B1/en not_active Expired - Lifetime
- 1990-11-16 HU HU907174A patent/HUT61047A/hu unknown
- 1990-11-16 AT AT90121961T patent/ATE214735T1/de not_active IP Right Cessation
- 1990-11-16 KR KR1019900018690A patent/KR910009929A/ko not_active Application Discontinuation
- 1990-11-16 DE DE69033937T patent/DE69033937T2/de not_active Expired - Fee Related
- 1990-11-16 JP JP02312577A patent/JP3121611B2/ja not_active Expired - Fee Related
- 1990-11-19 AR AR90318408A patent/AR246983A1/es active
- 1990-12-28 TW TW079110979A patent/TW205069B/zh active
-
1993
- 1993-11-24 US US08/156,792 patent/US5457034A/en not_active Expired - Lifetime
-
2000
- 2000-05-02 JP JP2000133485A patent/JP2001000194A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH03224490A (ja) | 1991-10-03 |
PL287811A1 (en) | 1991-12-02 |
TW205069B (xx) | 1993-05-01 |
KR910009929A (ko) | 1991-06-28 |
HUT61047A (en) | 1992-11-30 |
AU6655890A (en) | 1991-05-23 |
DE69033937D1 (de) | 2002-04-25 |
DE69033937T2 (de) | 2002-11-14 |
PE28191A1 (es) | 1991-10-28 |
JP2001000194A (ja) | 2001-01-09 |
CA2030108A1 (en) | 1991-05-17 |
CA2030108C (en) | 1998-04-28 |
NZ236058A (en) | 1993-04-28 |
ZA909122B (en) | 1991-09-25 |
AU645998B2 (en) | 1994-02-03 |
YU217890A (sh) | 1993-05-28 |
ATE214735T1 (de) | 2002-04-15 |
CN1051934A (zh) | 1991-06-05 |
EP0432510B1 (en) | 2002-03-20 |
FI905691A (fi) | 1991-05-17 |
ES2173856T3 (es) | 2002-11-01 |
JP3121611B2 (ja) | 2001-01-09 |
IT8948564A1 (it) | 1991-05-16 |
FI905691A0 (fi) | 1990-11-16 |
PT95911B (pt) | 1998-01-30 |
EP0432510A1 (en) | 1991-06-19 |
IE904120A1 (en) | 1991-05-22 |
IT8948564A0 (it) | 1989-11-16 |
IT1238348B (it) | 1993-07-13 |
IL96347A0 (en) | 1991-08-16 |
PT95911A (pt) | 1991-09-13 |
US5457034A (en) | 1995-10-10 |
HU907174D0 (en) | 1991-05-28 |
AR246983A1 (es) | 1994-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL96347A0 (en) | Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cells | |
EP0483085A3 (en) | Process of preparing electrode for fuel cell | |
GB2193499B (en) | Process for the genetic modification of yeast | |
AU1301792A (en) | Anti-sense regulation of gene expression in plant cells | |
SG83991G (en) | Cathode for electrolysis and process for producing the same | |
GB8909570D0 (en) | Compounds effective in inducing cell differentiation and process for preparing same | |
IL87622A0 (en) | Recombinant eukaryotic cells producing interleukin-2,process and vectors for their preparation and process for the preparation of interleukin-2 | |
IL96143A0 (en) | Methods for the production of proteins and polypeptides and for enhancement of cell growth | |
AU1446988A (en) | Genetic engineering process for the preparation of polypeptides | |
EG18596A (en) | Process for the preparation of peptide structure and immunogens containing them useful in the control of fertility | |
AU1782288A (en) | Process for the amplifying expression and transmission of cloned genes in eukaryotic cells | |
AU645998C (en) | Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cells | |
GB8716997D0 (en) | Cell culture vessel | |
GB9125052D0 (en) | Culture of bone cells | |
AU1492692A (en) | Co-expression in eukaryotic cells | |
AU2912989A (en) | Electrolytic cell and process | |
IL85935A0 (en) | Interleukin 3 producing cells and process for preparing interleukin 3 | |
IL84629A0 (en) | Process and device for the cultivation of mammalian cells in a suspension culture,and their use for the preparation of proteins | |
AU5966790A (en) | Genetic elements useful in production of active protein | |
ZA899150B (en) | Expression of hiv proteins in drosophila cells | |
IL74627A0 (en) | Genetic engineering process for the preparation of human gamma interferon and means for carrying out this process | |
GB8606728D0 (en) | Culture of plasmid-containing cells | |
IE893803L (en) | Expression of hiv proteins in drosophila cells | |
CS715986A1 (en) | Process for the cultivation of myelomic cells | |
GB8904951D0 (en) | Transformation of biological cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |